“…Infusion reactions have also less been described with telavancin, dalbavancin, and oritavancin. Other true AEs may include vancomycin nephrotoxicity [ 54 , 55 ] or elevated serum creatin-phosphokinase or rhabdomyolysis with daptomycin (2.8–3%) [ 56 , 57 ]. Data on newer lipoglycopeptide drugs indicate that dalbavancin showed reduced AEs in soft-tissue infections [ 58 ], with less nausea, diarrhea, and pruritus [ 59 , 60 ].…”